Day1
06/06 08:00-18:30
Main Hall
-
08:00-08:10Opening
-
08:10-nullSession 1 Live Transmission I
-
08:10-09:30Moderators
-
08:10-09:30Online Moderator
-
08:10-09:30
-
08:10-09:30Online Panelists
-
08:10-08:45Case 1: TAVR Cheng Hsin General Hospital ((振興醫院)
-
08:45-09:20Case 2: TAVR on pure AR Zhongshan Hospital, Fudan University (上海復旦大學附屬中山醫院)
-
09:20-09:30JenaValve Trilogy TAVR for Pure Aortic Regurgitation: NTUH Experience
-
09:30-10:30Session 2 TAVR, Re-Do & ViV: From Feasibility to Lifetime Strategy
-
09:30-10:30Moderators
-
09:30-10:30Online Moderator
-
09:30-10:30
-
09:30-09:42Current status of the OCEAN-SHD family
-
09:42-09:45Discussion
-
09:45-09:57Redo-TAVR: planning and execution
-
09:57-10:00Discussion
-
10:00-10:12CT Planning for Re-Do and ViV TAVR
-
10:12-10:15Discussion
-
10:15-10:27Lifetime management of aortic stenosis
-
10:27-10:30Discussion
-
10:30-11:30Session 3 Debate - TAVR should be the preferred treatment for all patients with severe aortic stenosis, regardless of age or surgical risk
-
10:30-11:30Moderators
-
10:30-11:30Online Moderator
-
10:30-11:30
-
10:30-11:30Online Panelists
-
Pro team: Argues for universal TAVR
-
Con team: Argues against universal TAVR
-
10:30-10:35Opening
-
Position statement for universal TAVR
-
10:35-10:51Pro Position (1st debater) – TAVR for All (8 minutes)
-
10:35-10:51Con Position (1st debater) – Selective TAVR (8 minutes)
-
Rebuttals
-
10:51-11:01Pro Rebuttal (2nd debater) (5 min)
-
10:51-11:01Con Rebuttal (2nd debater) (5 min)
-
11:01-11:11Crossfire Discussion
-
11:11-11:17Audience Q&A
-
Closing Statements
-
11:17-11:25Pro Side (3rd debater) (4 min)
-
11:17-11:25Con Side (3rd debater) (4 min)
-
11:25-11:30Final Vote and awarding
-
11:30-12:45Session 4 Transcatheter Mitral Valve Intervention
-
11:30-12:45Moderators
-
11:30-12:45Online Moderator
-
11:30-12:45Panelists
-
11:30-12:45Online Panelists
-
11:30-11:42The current status and future perspective of M-TEER: Insights from OCEAN-Mitral registry
-
11:42-11:45Discussion
-
11:45-11:57Transcatheter mitral valve replacement
-
11:57-12:00Discussion
-
12:00-12:12Mitral TEER: Pratical strategies for optimal results
-
12:12-12:15Discussion
-
12:15-12:27How to solve complex anatomy of M-TEER
-
12:27-12:30Discussion
-
12:30-12:42Role of Echo and CT in Transcatheter mitral valve-in-valve
-
12:42-12:45Discussion
-
12:45-14:05Session 5 Live Transmission II
-
12:45-14:05Moderators
-
12:45-14:05Online Moderator
-
12:45-14:05
-
12:45-14:05Online Panelists
-
12:45-13:25Case 3: T-TEER with DragonFly The Second Affiliated Hospital of Zhejiang University School of Medicine(浙江大學醫學院附屬第二醫院)
-
13:25-14:05Case 4: MTEER Beijing Anzhen Hospital Capital Medical University(首都醫科大學附屬北京安貞醫院)
-
14:05-15:11Session 6 Roundtable discussion – Coronary Re-access After TAVI / ViV / Redo TAVI
-
14:05-15:11Moderators
-
14:05-15:11Online Moderator
-
14:05-15:11Panelists
-
14:05-14:07Introduction
-
14:07-14:15Sinus sequestration in TAVR: How We Expect and Handle it
-
14:15-14:20Moderator-facilitated roundtable discussion
-
14:20-14:28TAVI in degenerated TAVI prothesis (TAVI-in-TAVI)
-
14:28-14:33Moderator-facilitated roundtable discussion
-
14:33-14:41TAVR with complex high risk CAD
-
14:41-14:46Moderator-facilitated roundtable discussion
-
14:46-14:54TAVI in Small annulus, small anatomy
-
14:54-14:59Moderator-facilitated roundtable discussion
-
14:59-15:07My most memorable TAVR case
-
15:07-15:11Discussion
-
15:11-16:34Session 7 Keynote Lectures
-
15:11-16:34Moderators
-
15:11-16:34
-
15:11-16:34Online Panelists
-
15:11-15:14Introduction
-
15:14-15:29Severe tricuspid regurgitation: Repair or Replacement?
-
15:29-15:44New recommendations concerning the management of asymptomatic AS raising from the new ESC/EACTS Guidelines
-
15:44-15:59Novel devices in transcatheter mitral valve therapy: From repair to replacement
-
15:59-16:14Aortic regurgitation and its treatment options
-
16:14-16:24TAVR-in-SAVR: current state of the art
-
16:24-16:34Discussion
-
16:34-17:30Session 8 Brain protection during TAVR
-
16:34-17:30Moderators
-
16:34-17:30Panelists
-
16:34-16:36Introduction
-
16:36-16:48Risk of stroke after TAVI according to THV types
-
16:48-17:00Evidence for Cerebral Protection: What Do the Trials Really Show?
-
17:00-17:10SENTINEL device deployment: The tips, tricks, and troubleshooting
-
17:10-17:20Cases sharing
-
17:20-17:30Panel discussion
-
17:30-18:30Session 9 Workshop - TAVR for Bicuspid Aortic Valve
-
17:30-18:30
-
17:30-18:30Online Moderator
-
17:30-18:30Panelists
-
17:30-18:30Online Panelists
-
17:30-17:33Introduction
-
17:33-17:45TAVI for bicuspid aortic valve stenosis - Prime time or still some way to go?
-
17:45-17:57Valve selection for bicuspid aortic valve
-
17:57-18:09From CT to Fluoroscopy: Insights from 7 Cases of Self-Expanding Valves
-
18:09-18:21CT-based sizing controversies (annulus vs supra-annular sizing)
-
18:21-18:30Discussion